Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events
Pancreatology · 2026-11
DOI: 10.1016/j.pan.2026.11.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2026-11. Verfasst von Shaina Ailawadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan, Ann Arbor, MI, USA. Electronic address: shainaai@med.umich.edu. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Michigan, Ann Arbor, MI, USA. Electronic address: shainaai@med.umich.edu.
- Bon Secours St. Francis Medical Center, Greenville, SC, USA.
- The Ohio State University, Columbus, OH, USA.
Zitieren
APA
Ailawadi, S., Elangovan, A., & Shah, R. (2026). Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events. Pancreatology. https://doi.org/10.1016/j.pan.2026.11.006
Vancouver
Ailawadi S, Elangovan A, Shah R. Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events. Pancreatology. 2026. doi:10.1016/j.pan.2026.11.006
BibTeX
@article{Ailawadi2026,
author = {Ailawadi, Shaina and Elangovan, Abbinaya and Shah, Raj},
title = {Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events},
journal = {Pancreatology},
year = {2026},
doi = {10.1016/j.pan.2026.11.006}
}
EUVIMED